LACTIC-ACID-BACTERIA-CONTAINING COMPOSITION, ORAL PHARMACEUTICAL COMPOSITION FOR TREATING HPV INFECTION AND/OR HPV-ASSOCIATED TUMORS, AND MUCOSAL IMMUNITY-INDUCING AGENT

EPO Patent Application EP 3254/693 A1
Application Date: Dec. 13rd, 2017

ABSTRACT

A lactic acid bacterium-containing composition including a lactic acid bacterium having a human papillomavirus (HPV) E7 protein-derived polypeptide on a surface thereof, wherein the HPV E7 protein-derived polypeptide is included...
Assignee(s):
Inventor(s):
KAWANA, Kei
IGIMI, Shizunobu
Application Number:
16743468.7
International Classification:
A61K 39/12 (20060101); A61P 15/00 (20060101); A61P 31/20 (20060101); A61P 35/00 (20060101); C07K 14/025 (20060101); C12N 1/20 (20060101); C12N 15/09 (20060101); C12R 1/245 (20060101)
No Pictures Available

CLAIMS

What is claimed is:

A lactic acid bacterium-containing composition comprising a lactic acid bacterium having a human papillomavirus (HPV) E7 protein-derived polypeptide on a surface thereof, wherein the HPV E7 protein-derived polypeptide is included in an amount of 0.03 µg to 1.0 µg per 1 × 108 lactic acid bacteria.

DESCRIPTION

Technical Field

The present invention relates to a lactic acid bacterium-containing composition in which a lactic acid bacterium has a human papilloma virus (HPV) E7 protein-derived polypeptide on a surface thereof, a therapeutic oral pharmaceutical composition for at least one of an HPV infectious disease and an HPV-associated tumor which includes the...
Back to Top